Monday, 25 April 2011 12:20

Vince & Associates Clinical Research Announces Multi-Million Dollar Clinical Pharmacology Expansion

Vince & Associates Clinical Research, a leading provider of Phase I-IV clinical trial services to the global biopharmaceutical industry announces the opening of their multi-million dollar, 90 bed Clinical Pharmacology Research Unit. This premier research facility is a culmination of years of planning and design by a team of over 50 clinical researchers led by Dr. Brad Vince, President and Medical Director of Vince & Associates Clinical Research.

The design delivers a boutique hotel experience for the study volunteers and a first class scientific research setting for the biopharmaceutical industry. Bedside 20-inch touch screen entertainment systems, in-house theater room, and individually themed luxury suites highlight the amenities that study volunteers appreciate. Clients receive the benefit of enhanced subject safety and security measures coupled with the Vince & Associates’ Physician Research Model where Principal Investigators lead and are intimately involved in all aspects of ongoing clinical studies.

“As a recognized industry leader with respect to subject recruitment, the luxurious amenities included in this expansion will allow us to better serve our biopharmaceutical clients on all levels including increased subject retention rates and enhanced safety monitoring features.” said Dr. Vince.

“The unit is purpose-built for the complex trials our clients require to make earlier drug development decisions and advance their drugs to market more aggressively than ever before. For example, we provide the full technical resources and medical expertise required for Phase I/IIa Proof of Concept (POC) studies which incorporate a single ascending dose (SAD), multiple ascending dose (MAD) and a patient proof of concept study into a single protocol.”

These designs offer significant time saving advantages to the client but require the expertise and facilities to ensure operational and scientific excellence. Vince and Associates has invested in facilities such as the addition of a USP 797-compliant Biosafety cabinet and full time pharmacy staff. This investment allows for sterile preparation from client’s API to be compounded on site as well as full capability to prepare drug extemporaneously, a common requirement for these early clinical trials. Other examples include the extensive laboratory areas for the processing of biomarkers, blood samples as well as strategic alliances for specialized testing.

About Vince and Associates Clinical Research:

Since its formation in 2001 Vince & Associates Clinical Research has grown to become one of the leading multi-specialty clinical research sites in the US offering Phase I-IV clinical trials. Dr. Vince and his team are well known for their recruitment and retention of research volunteers in clinical trials including disease state populations as well as healthy normal volunteers.
Read 1382 times

Leave a comment

Make sure you enter the (*) required information where indicated. HTML code is not allowed.

Want more? Visit...

Videos

  • ICON- Partnerships 12
    ICON- Partnerships 12 Steven Cutler, Group President of ICON discusses the launch of ICON's new acquisition of Firecrest at Partnerships in Clinical Trials 2012. Facing the continuing challenge of not only monitoring and…
    Read more...
  • ICON- Partnerships 12
    ICON- Partnerships 12 Steven Cutler, Group President of ICON discusses their exciting new partnership with Roche at Partnerships In Clinical Trials 2012. Medical imaging has always been a strong department within ICON. ICON…
    Read more...
  • ERT- Partnerships 12
    ERT- Partnerships 12 John Blakely, Executive Vice President and Chief Commercial Officer for ERT discusses the new trend in clinical research at Partnerships in Clinical Trials 2012 - the melding of objective and…
    Read more...
  • Chiltern- Partnerships 12
    Chiltern- Partnerships 12 Marcelo Piccirillo, Senior Clinical Research Physician for Chiltern, discusses new trends in gastrointestinal clinical development at Partnerships in Clinical Trials 2012. Current hot spots for clinical development in the field…
    Read more...
  • Blinded Diagnostics - Partnerships 12
    Blinded Diagnostics - Partnerships 12 Paul Savuto, President and CFO, and Steven Karrupan, CEO, from Blinded Diagnostics discuss Point of Care Technology at Partnerships in Clinical Trials 2012. Point of care (or decentralized testing) offers…
    Read more...
  • American Airlines - IQPC 2011
    American Airlines - IQPC 2011 American Airlines has globally launched a passive solutions that gives a new alternative to pharmaceutical manufacturers.
    Read more...

Podcasts